LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 25.41

Change

-0.04 (-0.16)%

Market Cap

N/A

Volume

400.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

+0.22 (+0.67%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

+0.03 (+0.14%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.42 (+1.17%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.37 (+0.82%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.12 (+0.47%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.04 (+0.36%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.68B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.81% 38% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.81% 38% F 39% F
Trailing 12 Months  
Capital Gain 8.59% 32% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.59% 32% F 34% F
Trailing 5 Years  
Capital Gain 17.20% 46% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.20% 46% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 2.23% 52% F 44% F
Dividend Return 2.39% 52% F 38% F
Total Return 0.16% 65% D 18% F
Risk Return Profile  
Volatility (Standard Deviation) 5.58% 73% C 89% A-
Risk Adjusted Return 42.80% 65% D 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike